The study compares the therapies of instant multivessel balloon angioplasty plus stent implantation or the balloon angioplasty plus stent implantation of the infarct artery alone with any possible graduated later treatment of the other vessels in patients with acute myocardial infarction with cardioganic shock. The main study hypothesis is to explore if culprit vessel only PCI with potentially subsequent staged revascularization in comparison to immediate multivessel revascularization by PCI in patients with cardiogenic shock complicating acute myocardial infarction reduces the incidence of 30- day mortality and/or severe renal failure requiring renal replacement therapy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
706
University of Goettingen
Göttingen, Germany
Heart Center Leipzig - University Hospital
Leipzig, Germany
University of Leipzig - Heart Center
Leipzig, Germany
30-day mortality and/or severe renal failure requiring renal replacement therapy
Time frame: 30 days
30-day mortality
Time frame: 30 days
Requirement of renal replacement therapy
Time frame: 30 days
Time to hemodynamic stabilization
Time frame: 30 days
Duration of catecholamine therapy
Time frame: 30 days
Serial creatinine-level creatinine-clearance
Time frame: 30 days
Length of ICU-stay
Time frame: 30 days
Serial intensive care scoring (SAPS-II score) until stabilization
Time frame: 30 days
Requirement and length of mechanical ventilation
Time frame: 30 days
All-cause death within 12 months follow-up
Time frame: 12 months
Recurrent infarction within 30-days follow-up
Time frame: 30 days
Death or recurrent infarction at 12 months follow-up
Time frame: 12 months
Rehospitalization for congestive heart failure within 12 months follow-up
Time frame: 12 months
Death/recurrent infarction/rehospitalization for congestive heart failure within 12 months
Time frame: 12 months
Need for repeat revascularization (PCI and/or CABG) within 12 months follow-up
Time frame: 12 months
Peak creatine kinase level during hospital stay
Time frame: 30 days
Quality of life at 6 and 12 months assessed using Euroqol 5D (EQ-5D)
Time frame: 12 months
Maximum creatine kinase-MB level
Time frame: 30 days
Maximum troponin level
Time frame: 30 days
Recurrent infarction within 12 months follow-up
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.